Description
Bremelanotide, also known as PT-141, is a synthetic cyclic peptide based on the alpha-MSH structure and acting as a non-selective melanocortin receptor agonist. It is studied as a probe of melanocortin signaling.
Non-clinical research in animal and cell models has examined melanocortin receptor activation, centrally driven behavioral responses, and downstream signaling cascades. Its defined receptor activity makes it a useful reference in melanocortin studies.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.